Sinha Debolina, Ghosh Amlan Kanti, Mukherjee Subhadeep, Biswas Ratna, Biswas Tapas
Division of Immunology, National Institute of Cholera and Enteric Diseases, Kolkata, India.
Division of Immunology, National Institute of Cholera and Enteric Diseases, Kolkata, India.
Cytokine. 2015 Dec;76(2):193-205. doi: 10.1016/j.cyto.2015.07.006. Epub 2015 Jul 11.
TLR-ligands are frequently chosen as candidates for vaccine or adjuvant development because they can primarily bridge innate signaling with adaptive immune responses. Since the adjuvant action of porin, the major outer membrane protein commonly present on Gram-negative bacteria, has been tested on several antigen-presenting cells, we investigated its role in driving systemic immunity which is considered a benchmark for a successful adjuvant. Here, we show porin differentially regulated splenic marginal zone (MZ) and follicular zone (FO) B cell responses in contrast to other classical TLR2-ligands FSL-1 and Pam3CSK4. The protein up-regulated TLR2 and TLR6 and stimulated the activation and costimulatory molecules on FO B cells skewing the cells toward TLR-dependent type-1 cytokine response. However, porin could not up-regulate the TLRs and activate MZ B cells. These cells responded to porin by expressing toll-interacting protein (TOLLIP), the TLR2 and -4 signaling inhibitor along with stimulation of the intracellular pathogen recognition receptor NLR caspase recruitment domain containing protein 5 (NLRC5). The CD1d(hi) MZ B cells released IL-10 unequivocally demonstrating regulatory B cell feature. Immunization with porin also resulted in transient IL-10 expression by the CD19(+)CD21(hi) B cells prior to plasma cell formation. Moreover, the plasma cells developed from the B-2 cell subsets show marked variation in generation of immunoglobulin subclasses. The work delineates multi-faceted role of B cell subsets induced by porin for robust immunity without compromising with the checks and controls.
Toll样受体(TLR)配体常被选作疫苗或佐剂开发的候选物,因为它们主要能将先天性信号传导与适应性免疫反应联系起来。由于孔蛋白(革兰氏阴性菌中常见的主要外膜蛋白)的佐剂作用已在多种抗原呈递细胞上进行了测试,我们研究了其在驱动全身免疫中的作用,全身免疫被认为是成功佐剂的一个基准。在此,我们发现与其他经典的TLR2配体FSL-1和Pam3CSK4相比,孔蛋白对脾边缘区(MZ)和滤泡区(FO)B细胞反应的调节存在差异。该蛋白上调了TLR2和TLR6,并刺激了FO B细胞上的激活分子和共刺激分子,使细胞偏向于依赖TLR的1型细胞因子反应。然而,孔蛋白不能上调TLR并激活MZ B细胞。这些细胞通过表达Toll相互作用蛋白(TOLLIP)、TLR2和-4信号抑制剂以及刺激含NLR半胱天冬酶募集结构域蛋白5(NLRC5)的细胞内病原体识别受体来响应孔蛋白。CD1d(hi) MZ B细胞明确释放白细胞介素-10,证明其具有调节性B细胞特征。用孔蛋白免疫还导致在浆细胞形成之前,CD19(+)CD21(hi) B细胞短暂表达白细胞介素-10。此外,从B-2细胞亚群发育而来的浆细胞在免疫球蛋白亚类的产生上表现出明显差异。这项工作描绘了孔蛋白诱导的B细胞亚群在不影响检查和控制的情况下对强大免疫的多方面作用。